3,4-Dehydro Cilostazol

3,4-Dehydro Cilostazol (OPC-13015) is an active metabolite of Cilostazol (CLZ; HY-17464) . 3,4-Dehydro Cilostazol is used for pharmacokinetic study[1].

Product Specifications

CAS Number

[73963-62-9]

Product Name Alternative

OPC-13015

UNSPSC

12352005

Hazard Statement

H302

Target

Drug Metabolite

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

Cancer-programmed cell death

Field of Research

Cancer; Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/3-4-dehydro-cilostazol.html

Concentration

10mM

Purity

98.09

Solubility

DMSO : 5 mg/mL (ultrasonic)

Smiles

O=C1NC2=C(C=C(OCCCCC3=NN=NN3C4CCCCC4)C=C2)C=C1

Molecular Formula

C20H25N5O2

Molecular Weight

367.44

Precautions

H302

References & Citations

[1]T R S Satheeshmanikandan, et al. Liquid Chromatography - Tandem Mass Spectrometry for the Simultaneous Quantitation of Glipizide, Cilostazol and Its Active Metabolite 3, 4-dehydro-cilostazol in Rat Plasma: Application for a Pharmacokinetic Study. Arzneimittelforschung. 2012 Sep;62 (9) :425-32.